Vivos Therapeutics Acquires The Sleep Center of Nevada

Vivos Therapeutics, a company specializing in sleep wellness and health through non-invasive treatments for obstructive sleep apnea (OSA), has successfully completed the acquisition of The Sleep Center of Nevada (SCN). This acquisition marks Vivos' first significant entry into the medical sleep testing and practice arena, complementing its existing portfolio and enhancing its revenue streams. The acquisition aligns with Vivos' strategic pivot aimed at capturing high-volume patient centers and securing higher margin revenues by integrating medical sleep practices that diagnose and consult on sleep disorders. Vivos financed the acquisition with over $11 million from a combination of senior secured loans and equity private placements provided by existing investors like Streeterville Capital and New Seneca Partners. The deal involves a $6 million cash payment complemented by common stock issuances, with additional stock contingent upon financial milestones. SCN will now operate under Vivos, incorporating Vivos’ proprietary treatment methodologies. Vivos anticipates substantial growth in its revenue as SCN fully integrates into its operations over the next 12 to 18 months, aided by the opportunity to directly offer Vivos’ patented OSA appliances to a large patient base that has historically been referred out for alternative treatments. As part of its growth plan, Vivos aims to pursue additional acquisitions and collaborations, positioning itself as a leader in sleep wellness by addressing the significant gap in diagnostic and treatment solutions for OSA and related conditions. This aligns with its broader ambitions to reshape the market for sleep disorder treatments through innovation and strategic partnerships.